TRIL - Trillium Therapeutics - Stock Forecast

Coverage Performance Price Targets & Ratings Chart Insider Trading

with an average price target of $6.48. This is a potential upside of $6.48 (0%) from yesterday's end of day stock price of $0.

Trillium Therapeutics's activity chart (see below) currently has 1 price targets and 2 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 33.33% with an average time for these price targets to be met of 40.5 days.

Most recent stock forecast was given by AYDIN HUSEYNOV from LADENBURG on 17-Nov-2021. First documented stock forecast 14-Apr-2021.

Best performing analysts who are covering TRIL - Trillium Therapeutics:

Swayampakula Ramakanth Aydin Huseynov

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

21

2 years 5 months 7 days ago

0/1 (0%)

$10.76 (105.08%)

Buy

18

$-0.44 (-2.39%)

22

2 years 8 months 1 days ago

2/3 (66.67%)

$2.2 (21.93%)

81

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is TRIL (Trillium Therapeutics) average time for price targets to be met?

On average it took 40.5 days on average for the stock forecasts to be realized with a an average price target met ratio 33.33

Which analyst has the current highest performing score on TRIL (Trillium Therapeutics) with a proven track record?

SWAYAMPAKULA RAMAKANTH

Which analyst has the current lower performing score on TRIL (Trillium Therapeutics) with a proven track record?

AYDIN HUSEYNOV

Which analyst has the most public recommendations on TRIL (Trillium Therapeutics)?

Swayampakula Ramakanth has 4 price targets and 3 ratings on TRIL

Which analyst is the currently most bullish on TRIL (Trillium Therapeutics)?

Aydin Huseynov with highest potential upside - $0

Which analyst is the currently most reserved on TRIL (Trillium Therapeutics)?

Swayampakula Ramakanth with lowest potential downside - -$0.44

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?